These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


58 related items for PubMed ID: 11034877

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine.
    Sethi A, Chandra D, Puri V, Mallika V.
    Neurol India; 2002 Sep; 50(3):359-63. PubMed ID: 12391470
    [Abstract] [Full Text] [Related]

  • 3. A beneficial effect on mood in partial epilepsy patients treated with gabapentin.
    Harden CL, Lazar LM, Pick LH, Nikolov B, Goldstein MA, Carson D, Ravdin LD, Kocsis JH, Labar DR.
    Epilepsia; 1999 Aug; 40(8):1129-34. PubMed ID: 10448827
    [Abstract] [Full Text] [Related]

  • 4. Choreoathetotic movements: A possible side effect of gabapentin.
    Buetefisch CM, Gutierrez A, Gutmann L.
    Neurology; 1996 Mar; 46(3):851-2. PubMed ID: 8618709
    [No Abstract] [Full Text] [Related]

  • 5. [Safety and tolerability of gabapentin].
    Viteri C.
    Rev Neurol; 1996 Mar; 34(3):292-5. PubMed ID: 12022084
    [Abstract] [Full Text] [Related]

  • 6. Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability.
    Mikati MA, Choueri R, Khurana DS, Riviello J, Helmers S, Holmes G.
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():57-62. PubMed ID: 10030434
    [Abstract] [Full Text] [Related]

  • 7. Gabapentin.
    Chadwick D.
    Epilepsy Res Suppl; 1991 Dec; 3():183-6. PubMed ID: 1777078
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Gabapentin toxicity in children manifesting as behavioral changes.
    Wolf SM, Shinnar S, Kang H, Gil KB, Moshé SL.
    Epilepsia; 1995 Dec; 36(12):1203-5. PubMed ID: 7489697
    [Abstract] [Full Text] [Related]

  • 10. Gabapentin--a new anticonvulsant.
    Med Lett Drugs Ther; 1994 Apr 29; 36(921):39-40. PubMed ID: 8159133
    [No Abstract] [Full Text] [Related]

  • 11. Alopecia associated with gabapentin: first case.
    Picard C, Jonville-Bera AP, Billard C, Autret E.
    Ann Pharmacother; 1997 Oct 29; 31(10):1260. PubMed ID: 9337455
    [No Abstract] [Full Text] [Related]

  • 12. Gabapentin associated with aggressive behavior in pediatric patients with seizures.
    Tallian KB, Nahata MC, Lo W, Tsao CY.
    Epilepsia; 1996 May 29; 37(5):501-2. PubMed ID: 8617181
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical efficacy and safety of gabapentin.
    Ramsay RE.
    Neurology; 1994 Jun 29; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Conversion from thrice daily to twice daily administration of gabapentin (GBP) in partial epilepsy: analysis of clinical efficacy and plasma levels.
    Muscas GC, Chiroli S, Luceri F, Mastio MD, Balestrieri F, Arnetoli G.
    Seizure; 2000 Jan 29; 9(1):47-50. PubMed ID: 10667963
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.